Official UK procurement notice
Drugs of Abuse and Wider Point of Care Testing
Authority: NHS Shared Business Services Limited (NHS & healthcare)
What is being bought
Published requirement descriptionNHS SBS is looking to expand the scope of their current Point of Care Testing: Drugs of Abuse framework agreement to include the below potential areas –
- Rapid Drug Testing (oral, urine and hair)
- Pandemic Testing (Antigen & Antibody)
- Family Law Services including DNA Testing
- Blood Born Virus Testing
- Blood Spot Drug & Alcohol testing
- Alcohol Testing Devices, including Breath Analysers, Continuous Monitoring (SCRAM) and Associated Consumables
- Confirmation/Classification Testing/Screening of Non-Negative Samples
- Operational Outsourcing of Services
NHS SBS are open to expanding this scope further, suppliers should complete the RFI with their suggestions.
Innovation will continue to be a key focus of the framework agreement, awarded suppliers will have the option to add innovative products/services to the framework throughout the duration of the Agreement.
CPV: Analysers · Blood analysers · Blood-testing reagents · Checking and testing apparatus · Drug detection apparatus · Laboratory reagents · Laboratory services · Machines and apparatus for testing and measuring · Reagent strips
The lotProcurement structure
single lot · no lot value publishedLot #1Prior Information Notice (PIN) for Drugs of Abuse and Wider Point of Care Testing…Planned
Prior Information Notice (PIN) for Drugs of Abuse and Wider Point of Care Testing framework agreement. NHS Shared Business Services (NHS SBS) are consulting on a proposal to tender for the provision of Drugs of Abuse and Wider Point of Care Testing to support NHS Organisations and the wider public sector to replace the existing framework agreement which will expire in December 2021.
To help define and develop our national procurement strategy and help in the development of our service specification to meet the needs of NHS Organisations and wider Public Sectors, NHS SBS are engaging with potential providers prior to the release of any official tender documents.
Procedure terms & legal framework
From the official record · publisher note attached- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Past planning notice
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 8 Apr 2021, 12:06 BST
- Last source update
- 8 Apr 2021, 12:06 BST
- FTS notice number
2021/S 000-007215- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02a3a0Find a Tender
Publisher note: An expression of interest in the Drugs of Abuse and Wider Point of Care Testing PIN is not a tender response. An expression of interest is no indication of a commitment to participate in the tender nor does it infer any special status on those providers who do submit interest. Potential providers who do not express an interest will still be able to apply in the future. This expression of interest does not commit the NHS SBS to undertake the procurement. Suppliers should complete the RFI and send this to [email protected] to register their interest by 10th May 2021 at 12pm.
How it was run
Official notice- Submission deadline
- —
Timeline
8 Apr 2021 → 1 Sept 2021 · 2 dates- Notice published8 Apr 2021, 12:06 BST
- Tender notice expected1 Sept 2021, 00:00 BST
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.